# Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

> **NCT02836288** · EARLY_PHASE1 · COMPLETED · sponsor: **Scott A. Irwin, MD, PhD** · enrollment: 4 (actual)

## Conditions studied

- Cancer
- Depression

## Interventions

- **DRUG:** Ketamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02836288
- **Lead sponsor:** Scott A. Irwin, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-20
- **Primary completion:** 2018-05-29
- **Final completion:** 2018-05-29
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2018-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836288, "Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02836288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*